• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments

    3/4/26 4:35:00 AM ET
    $PHG
    Medical Electronics
    Health Care
    Get the next $PHG alert in real time by email

    March 4, 2026

    • CE Marked and 510(k) pending, Rembra's advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real time
    • With the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging and trauma, helping to improve comfort for complex patients and may reduce the need for rescans
    • Next-generation NanoPanel Precise XD detector with AI is built for dose-efficient, high-resolution imaging to support clear visualization and delineation of anatomical structures

    Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today introduced Rembra [3], its next-generation radiology CT system designed for the realities of acute and high-demand imaging. Rembra will be showcased publicly for the first time at ECR 2026 in Vienna.

    Healthcare systems worldwide are under unprecedented pressure. Rising patient volumes, increasing clinical complexity and workforce shortages are pushing frontline, high-acuity and high-demand imaging to its limits. Rembra was engineered from the ground up to meet these challenges, bringing together advanced detector technology, ultra-fast scan and reconstruction speeds and streamlined workflows in a system built for speed, consistency and long-term value.

    "Rembra is built for the realities that clinicians face every day," said Dan Xu, Business Leader for Computed Tomography at Philips. "By combining our most advanced detector technology with AI-powered workflows and industry-leading speed, Rembra represents a significant step forward for high-acuity imaging, delivering speed, access and diagnostic confidence when it matters most."

    Industry-leading speed [1] to support timely clinical decisions

    In emergency, trauma and other high-demand settings, delays in image reconstruction can slow diagnosis and impact outcomes. Rembra addresses this challenge with an industry-leading reconstruction speed – up to 106 images per second [1]. This speed is designed to help radiologists and clinicians access images quickly in stroke, trauma and other urgent cases. It may support smoother workflows and timely clinical decisions in busy emergency departments.

    Designed for high-demand environments, Rembra can support 270 exams per day [2], helping imaging departments manage growing volumes without compromising speed or confidence.

    Optimized patient positioning and access

    With the largest-in-class 85 cm bore, Rembra is designed to help facilitate patient access and positioning, and may help improve comfort for trauma, bariatric and interventional cases.

    Rembra features a 60 cm standard field of view (sFOV) and an 85 cm extended field of view (eFOV), both the largest in their class of frontline radiology CT systems [4], enabling full anatomical visualization in a single scan. Rembra also features a high-performance patient table with Philips' best-in-class scan range of up to 2.3 meters and gantry-to-tablespace of 46 cm to support flexible patient positioning.

    "In interventional and high acuity settings, precise access and efficient positioning are essential," said Professor Olivier Rouvière, MD, PhD, Head of Department at Hospices Civils de Lyon (Centre Hospitalier Universitaire de Lyon). "Rembra's 85 cm bore supports improved access as well as faster and safer positioning of long needles and instruments in complex procedures."

    Clinical performance without compromise

    At the heart of Rembra is Philips' newest NanoPanel Precise XD, a high-density detector designed from the outset to work hand-in-hand with AI. It delivers high dose-efficiency, high-resolution imaging at the source and is designed to support overall image quality and diagnostic confidence.

    The detector offers exceptional in-plane spatial resolution of 23 line pairs per cm, enabling sharp detail and visualization of fine anatomical structures down to 0.25 mm. A 2D anti-scatter grid provides strong scatter rejection to help preserve image clarity in challenging patient types, supporting consistently high image quality across patient sizes and clinical scenarios.

    AI-designed for productivity, predictability and long-term value

    Integrated AI-enabled smart workflows can help automate routine steps and simplify certain operations. These features are intended to support workflow efficiency for consistent results.

    Built for operations at high-altitude environments up to 5000m, Rembra is engineered for reliability, durability and long-term performance, supporting a system lifetime of up to 20 years with required maintenance and upgrades. Philips' industry-first Tube for Life [5] service program further enhances cost predictability by covering tube replacement costs for up to 10 years.

    Advancing spectral CT leadership

    Also making its European debut at ECR 2026 is Verida, the world's first detector-based spectral CT powered by AI. Verida integrates AI across the entire imaging chain. First introduced at RSNA 2025, Verida delivers exceptional spectral image quality while helping to accelerate workflows and reduce dose, further reinforcing Philips' leadership in spectral CT innovation [6,7]. For more information about Verida, please visit the Verida spectral-detector CT scanner page.

    [1] Based on publicly available manufacturer specifications for leading radiology CT systems as of March 2026 on reconstruction speed in this class of scanners and bore size.

    [2] Based on a sixteen-hour day, with throughput testing with 203 patient scans/ 12 hours for Rembra with typical radiological profiles and protocols.

    [3] Pending 510(k) - not available for sale in the USA

    [4] The Extended Field of View (EFOV) of 85 cm is intended solely for use in treatment preparation and the planning/simulation of radiation therapy. It cannot be used for diagnostic purposes. The water equivalent material external contour deviation of body system phantom positioned (partially) outside scan FOV with phantom edge adjacent to bore cover shall be within 1mm in terms of mean Hausdorff distance compared to the true external contour.

    [5] Tube for Life guarantee availability varies by country. Please contact your local Philips sales representative for details

    [6] Andersen MB et al. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol2020. doi.org/10.1007/s00330-020-06878-7

    [7] Andersen MB et al. Economic impact of spectral body imaging in the diagnosis of patients suspected of occult cancer. Insights into Imaging 2021. doi.org/10.1186/s13244-021-01116-0. Results of customer testimonies are not predictive of results in other cases, where results may vary.

    For further information, please contact:

    Jayme Maniatis 

    Philips Global External Relations  

    Tel.: +1 617 804 8368

    E-mail: [email protected]

    About Royal Philips

    Royal Philips (NYSE:PHG, AEX: PHIA)) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.



    Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

    Attachments

    • Philips unveils Rembra CT at ECR 2026
    • Philips Rembra, a next-generation radiology CT system designed for the realities of acute and high-demand imaging


    Primary Logo

    Get the next $PHG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PHG

    DatePrice TargetRatingAnalyst
    12/17/2025Sector Perform
    RBC Capital Mkts
    2/25/2025Neutral → Outperform
    Exane BNP Paribas
    2/20/2025Neutral → Buy
    UBS
    10/29/2024Underperform → Hold
    Jefferies
    5/13/2024Mkt Perform → Outperform
    Bernstein
    5/7/2024Underperform → Neutral
    Exane BNP Paribas
    4/30/2024Sell → Neutral
    UBS
    4/30/2024Underweight → Neutral
    JP Morgan
    More analyst ratings

    $PHG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments

    March 4, 2026 CE Marked and 510(k) pending, Rembra's advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real timeWith the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging and trauma, helping to improve comfort for complex patients and may reduce the need for rescansNext-generation NanoPanel Precise XD detector with AI is built for dose-efficient, high-resolution imaging to support clear visualization and delineation of anatomical structures Amsterdam,

    3/4/26 4:35:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments

    March 3, 2026 With a total budget of EUR 21.5 million, the four-year SHERPA research project is coordinated by Philips and co-funded by the EU Innovative Health Initiative (IHI) and industry partnersThe project focuses on developing automated workflows for minimally invasive neurovascular and tumor treatments – clinical procedures where staffing levels and specialized expertise are in short supplyThe clinical studies are being conducted at University Medical Center Utrecht, St Antonius Hospital, University Medical Center Hamburg-Eppendorf, Hôpital Bicêtre AP-HP, and Hospital de la Santa Creu i Sant PauOn March 4 (16:30 - 17:30 CET), SHERPA will be featured at the European Congress of Radiol

    3/3/26 4:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips publishes its Annual Report 2025

    February 19, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today published its Annual Report 2025. Philips' Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to file the report on Form 20-F with the U.S. Securities and Exchange Commission later today (www.sec.gov). The Annual Report 2025 (in

    2/19/26 4:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    SEC Filings

    View All

    SEC Form 20-F filed by Koninklijke Philips N.V. NY Registry Shares

    20-F - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

    2/19/26 6:40:43 AM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

    6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

    2/19/26 6:37:30 AM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

    6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

    2/10/26 7:58:39 AM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Philips

    RBC Capital Mkts initiated coverage of Philips with a rating of Sector Perform

    12/17/25 9:26:42 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips upgraded by Exane BNP Paribas

    Exane BNP Paribas upgraded Philips from Neutral to Outperform

    2/25/25 7:12:36 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips upgraded by UBS

    UBS upgraded Philips from Neutral to Buy

    2/20/25 7:05:01 AM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    Leadership Updates

    Live Leadership Updates

    View All

    Philips proposes to re-appoint CEO Roy Jakobs

    February 10, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive Officer and member of the Board of Management. The decision to propose the re-appointment of Roy Jakobs reflects the Supervisory Board's recognition of the progress made since 2022 and its confidence in his leadership as Philips enters the next phase of driving profitable growth. The proposal will be submitted for approval at the upcoming Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. "Roy Jakobs has demonstrated clear leadership, strong execution

    2/10/26 12:55:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    New AI Rollouts Signal Shift From Hype to Healthcare Reality

    USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- With populations again, and chronic diseases on the rise, global healthcare systems are facing enormous challenges ahead. However, there is hope on the horizon to alleviate some of these burdens, coming from the rise of AI in healthcare, as the new tech is proving it can improve diagnostic accuracies, drug discoveries, and administration work flow. Healthcare leaders are already reporting benefits, including reduced clinician workloads through voice-based AI tools and the use of AI agents to boost efficiency and support smarter care delivery. Behind the scenes, the tech is b

    6/24/25 9:45:00 AM ET
    $LLY
    $PHG
    $PLTR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Electronics
    Computer Software: Prepackaged Software

    Philips shareholders approve all proposals at the AGM 2025

    May 8, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The re-appointment of Ms Indra Nooyi and Ms Chua Sock Koong as members of the Supervisory Board.The appointment of Mr Bob White as a new member of the Supervisory Board.The re-appointment of Mr Marnix van Ginneken as member of the Board of Management. The discharge of the members of the Board of Management, and of the members of the Supervisory Board.A full overview of the resolutions taken at the AGM 2025 can be found below. Feike Sijbesma, Chairman of Philips' Supervisory Board, sa

    5/8/25 12:16:51 PM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    Financials

    Live finance-specific insights

    View All

    Emergency Care Holdings Acquires Philips Emergency Care Business, Launching Global Emergency Care Platform

    Transaction establishes a scalable platform positioned for consolidation and growth in a $26B global emergency medical products market Emergency Care Holdings (ECH), a platform backed by Bridgefield Capital, today announced the completion of its acquisition of the Philips Emergency Care business from Koninklijke Philips N.V. (NYSE:PHG). The business will operate as Heartstream and continue to market select products under a Philips brand license. The acquisition represents the launch of ECH's global platform strategy focused on building a leading portfolio of emergency medical technology companies serving the pre-hospital care market. The emergency medical products sector exceeds $26 bil

    1/14/26 10:31:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips continues momentum; delivers strong order intake, step-up in sales growth and margin expansion

    November 4, 2025Q3 2025 Group Highlights Comparable order intake growth 8%Group sales amounted to EUR 4.3 billion, reflecting 3% increase in comparable salesIncome from operations was EUR 330 millionAdjusted EBITA margin increased by 50 basis points to 12.3% of salesOperating cash flow of EUR 327 million, with a free cash flow of EUR 172 millionPhilips reiterates full-year 2025 outlook, with margin now expected at the upper end of the range Roy Jakobs, CEO of Royal Philips:"In this quarter we maintained our momentum, with AI-powered innovations and long-term partnerships making a real difference for patients and consumers. We drove strong order intake and accelerated sales growth, with sus

    11/4/25 1:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips builds strong order intake momentum and drives margin expansion in Q2

    July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6%Group sales EUR 4.3 billion, reflecting 1% increase in comparable salesIncome from operations EUR 400 millionAdjusted EBITA margin increased 130 bps to 12.4% of salesFree cash flow increased to EUR 230 millionPhilips increases full year 2025 outlook for Adjusted EBITA margin and free cash flow; reiterates comparable sales growth outlook Roy Jakobs, CEO of Royal Philips:"We are focused on driving profitable growth and delivering better care for more people. We built order intake growth momentum, supported by our recently launched AI-powered innovations. Our multi-year agreement with the Indonesian Ministry of Health re

    7/29/25 1:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Koninklijke Philips N.V. NY Registry Shares

    SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

    6/25/24 4:35:57 PM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form SC 13D/A filed by Koninklijke Philips N.V. NY Registry Shares (Amendment)

    SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

    5/16/24 5:52:57 PM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form SC 13D filed by Koninklijke Philips N.V. NY Registry Shares

    SC 13D - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

    8/23/23 12:44:28 PM ET
    $PHG
    Medical Electronics
    Health Care